General Pharmaceutical Council issues reminder to pharmacy professionals about valproate and the risk of birth defects

The GPhC is reminding pharmacy professionals of what they must do to ensure women and girls receive the right information about valproate and the risk of birth defects. This coincides with a letter from NHS England to all women and girls aged 12-55 currently on valproate.

Source:

General Pharmaceutical Council